Serveur d'exploration sur l'Indium

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Le cluster Antibodies, Monoclonal (diagnostic use) - United States

Terms

7Antibodies, Monoclonal (diagnostic use)
6United States
5United States Food and Drug Administration
9Sensitivity and Specificity
4Reproducibility of Results
3Drug Approval
4Prostatic Neoplasms (radionuclide imaging)
3Prostate-Specific Antigen (blood)

Associations

Freq.WeightAssociation
33Antibodies, Monoclonal (diagnostic use) - United States
55United States - United States Food and Drug Administration
44Sensitivity and Specificity - United States
33Sensitivity and Specificity - United States Food and Drug Administration
33Reproducibility of Results - Sensitivity and Specificity
33Drug Approval - United States
33Drug Approval - United States Food and Drug Administration
33Drug Approval - Sensitivity and Specificity
33Antibodies, Monoclonal (diagnostic use) - Sensitivity and Specificity
33Antibodies, Monoclonal (diagnostic use) - Prostatic Neoplasms (radionuclide imaging)
33Antibodies, Monoclonal (diagnostic use) - Prostate-Specific Antigen (blood)
22Prostatic Neoplasms (radionuclide imaging) - United States
22Prostatic Neoplasms (radionuclide imaging) - United States Food and Drug Administration
22Prostatic Neoplasms (radionuclide imaging) - Sensitivity and Specificity
22Prostate-Specific Antigen (blood) - Prostatic Neoplasms (radionuclide imaging)
22Drug Approval - Prostatic Neoplasms (radionuclide imaging)

Documents par ordre de pertinence
000077 (1996) Monoclonal antibody scan holds promise for prostate cancer staging.
000066 (1998) Radioimmunoscintigraphy for prostate cancer.
000067 (1998) Indium-111 satumomab pendetide: the first FDA-approved monoclonal antibody for tumor imaging.
000041 (2005) The role of imaging with (111)In-ibritumomab tiuxetan in the ibritumomab tiuxetan (zevalin) regimen: results from a Zevalin Imaging Registry.
000032 (2008) Use of local (111)in-capromab pendetide scan results to predict outcome after salvage radiotherapy for prostate cancer.
000023 (2010) Competitive multi-immunosensing of pesticides based on the particle manipulation with negative dielectrophoresis.
000031 (2009) Chitosan/polyaniline hybrid conducting biopolymer base impedimetric immunosensor to detect Ochratoxin-A.
000045 (2005) Biochemical recurrence after definitive prostate cancer therapy. Part I: defining and localizing biochemical recurrence of prostate cancer.
000052 (2002) From the Food and Drug Administration.
000076 (1996) Radiation absorbed dose from indium-111-CYT-356.
000114 (1986) Radiopharmaceutical approved for the labeling of autologous leukocytes.
000013 (2011) Photoelectrochemical competitive DNA hybridization assay using semiconductor quantum dot conjugated oligonucleotides.
000047 (2004) Classification of German white wines with certified brand of origin by multielement quantitation and pattern recognition techniques.
000068 (1998) Impact of radioimmunoscintigraphy on the management of colorectal and ovarian cancer patients: a retrospective study.
000078 (1996) Inhibition of renal uptake of indium-111-DTPA-octreotide in vivo.
000088 (1994) Inter- and intrasubject variability of solid and liquid gastric emptying parameters. A scintigraphic study in healthy subjects and diabetic patients.

Wicri

This area was generated with Dilib version V0.5.76.
Data generation: Tue May 20 07:24:43 2014. Site generation: Thu Mar 7 11:12:53 2024